KT&G Life Sciences Overview
- Founded
-
2002
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
KT&G Life Sciences General Information
Description
Developer of medicines and drugs. The company is researching drugs for treating Cancer, Obesity, Type-2 Diabetes, Liver Disease, MELAS Syndrome, Dry Eye Syndrome, Atopic Dermatitis and other metabolic diseases.
Contact Information
Website
www.ktnglifesciences.com
Formerly Known As
Mazence
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- B-1004-6 Digital Empire Building 16
- Deogyang-daero 1556 beon-gil Yeongtong-gu
- Suwon-si, Gyeonggi-do 443-702
- South Korea
KT&G Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
KT&G Life Sciences Patents
KT&G Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20120289577-A1 | Composition for treating or preventing hearing loss comprising naphthoquinone-based compounds | Abandoned | 28-Dec-2009 | 0000000000 | |
| EP-2520294-A4 | Composition including naphthoquinone compound for treating and preventing hearing loss | Granted | 28-Dec-2009 | 0000000000 | |
| EP-2520294-B1 | Composition including a naphthoquinone derivative for treating and preventing hearing loss | Not-In-Force | 28-Dec-2009 | 0000000000 | |
| EP-2520294-A2 | Composition including naphthoquinone compound for treating and preventing hearing loss | Granted | 28-Dec-2009 | 0000000000 | |
| JP-2013515765-A | Composition for treatment or prevention of hearing loss comprising naphthoquinone compound | Granted | 28-Dec-2009 | A61K31/352 |
KT&G Life Sciences Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
KT&G Life Sciences Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|